Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience-Reference-Cited by-同舟云学术

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Published:2013-01-31 Issue:3 Volume:71 Page:663-670
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Fine Robert L.,Gulati Anthony P.,Krantz Benjamin A.,Moss Rebecca A.,Schreibman Stephen,Tsushima Dawn A.,Mowatt Kelley B.,Dinnen Richard D.,Mao Yuehua,Stevens Peter D.,Schrope Beth,Allendorf John,Lee James A.,Sherman William H.,Chabot John A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-012-2055-z.pdf

Reference29 articles.

1. Viola KV, Sosa JA (2005) Current advances in the diagnosis and treatment of pancreatic endocrine tumors. Curr Opin Oncol 17(1):24–27

2. Gibril F, Doppman JL, Jensen RT (1995) Recent advances in the treatment of metastatic pancreatic endocrine tumors. Semin Gastrointest Dis 6(2):114–121

3. Rinke A, Muller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Blaker M, Harder J, Arnold C, Gress T, Arnold R (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27(28):4656–4663. doi: 10.1200/JCO.2009.22.8510

4. Cheng PN, Saltz LB (1999) Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma. Cancer 86(6):944–948

5. Sun W, Lipsitz S, Catalano P, Mailliard JA, Haller DG (2005) Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol 23(22):4897–4904. doi: 10.1200/JCO.2005.03.616

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Retreatment with¹⁷⁷Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States;Journal of Nuclear Medicine;2024-03-21

2. Liver transplant for primary biliary tract neuroendocrine tumor in a nine‐year‐old girl;Pediatric Transplantation;2024-03

3. Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms;Endocrine-Related Cancer;2024-01-12

4. The clinical implication and translational research of OSCC differentiation;British Journal of Cancer;2024-01-05

5. MEN1 Bone Complications;Endocrinology;2024